Por favor, use este identificador para citar o enlazar este ítem:
http://dx.doi.org/10.1155/2015/465342
Twittear
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Talavera López, Jesús | - |
dc.contributor.author | Giraldo, Alejandro | - |
dc.contributor.author | Fernández del Palacio, María Josefa | - |
dc.contributor.author | García-Nicolás, Obdulio | - |
dc.contributor.author | Seva, Juan | - |
dc.contributor.author | Brooks, Gavin | - |
dc.contributor.author | Moraleda, Jose María | - |
dc.contributor.other | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Medicina y Cirugía Animal | es |
dc.coverage.spatial | España | es |
dc.coverage.temporal | 2015 | es |
dc.date.accessioned | 2024-01-29T11:39:04Z | - |
dc.date.available | 2024-01-29T11:39:04Z | - |
dc.date.issued | 2015-12-01 | - |
dc.identifier.issn | Print 2314-6133 | - |
dc.identifier.issn | Electronic 2314-6141 | - |
dc.identifier.uri | http://hdl.handle.net/10201/137937 | - |
dc.description | Copyright © 2015 Jesus Talavera et al. This is an open access article distributed under the Creative Commons Attribution License, ´ which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | - |
dc.description.abstract | Current protocols of anthracycline-induced cardiomyopathy in rabbits present with high premature mortality and nephrotoxicity, thus rendering them unsuitable for studies requiring long-term functional evaluation of myocardial function (e.g., stem cell therapy). We compared two previously described protocols to an in-house developed protocol in three groups: Group DOX2 received doxorubicin 2 mg/kg/week (8 weeks); Group DAU3 received daunorubicin 3 mg/kg/week (10 weeks); and Group DAU4 received daunorubicin 4mg/kg/week (6 weeks). A cohort of rabbits received saline (control). Results of blood tests, cardiac troponin I, echocardiography, and histopathology were analysed. Whilst DOX2 and DAU3 rabbits showed high premature mortality (50% and 33%, resp.), DAU4 rabbits showed 7.6% premature mortality. None of DOX2 rabbits developed overt dilated cardiomyopathy; 66% of DAU3 rabbits developed overt dilated cardiomyopathy and quickly progressed to severe congestive heart failure. Interestingly, 92% of DAU4 rabbits showed overt dilated cardiomyopathy and 67% developed congestive heart failure exhibiting stable disease. DOX2 and DAU3 rabbits showed alterations of renal function, with DAU3 also exhibiting hepatic function compromise. Thus, a shortened protocol of anthracycline-induced cardiomyopathy as in DAU4 group results in high incidence of overt dilated cardiomyopathy, which insidiously progressed to congestive heart failure, associated to reduced systemic compromise and very low premature mortality. | es |
dc.format | application/pdf | es |
dc.format.extent | 14 | es |
dc.language | eng | es |
dc.relation | Fundacio ́n Se ́neca, Agencia de Ciencia y Tec- nolog ́ıa, Regio ́n de Murcia, Spain (Jesu ́s Talavera) (Grant no. 11935/PI/09), Red de Terapia Celular, ISCIII-Sub. Gral. Redes, VI PN de I+D+I 2008-2011 (Grant no. RD12/0019/0001) (Jose ́ M. Moraleda), Cofinanciado con Fondos Estructurales de la Unio ́n Europea (FEDER) (Jose ́ M. Moraleda), and University of Reading, United Kingdom (Alejandro Giraldo and Gavin Brooks) (central funding). | es |
dc.rights | info:eu-repo/semantics/openAccess | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología | es |
dc.title | An Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.doi | http://dx.doi.org/10.1155/2015/465342 | - |
Aparece en las colecciones: | Artículos: Medicina y Cirugía Animal |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
PDF DEFINITIVO PUBLICADO BRMI.pdf | 4,78 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons